Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T
Authors:
- Gaël DournesGDGaël Dournes
- David GrodzkiDGDavid Grodzki
- Julie MaceyJMJulie Macey
- Pierre-Olivier GirodetPGPierre-Olivier Girodet
- Michaël FayonMFMichaël Fayon
- Jean-François ChateilJCJean-François Chateil
- Michel MontaudonMMMichel Montaudon
- Patrick BergerPBPatrick Berger
- François LaurentFLFrançois Laurent
- 1 July 2015
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 276 (1) , 258-265
Abstract
To assess lung magnetic resonance (MR) imaging with a respiratory-gated pointwise encoding time reduction with radial acquisition (PETRA) sequence at 1.5 T and compare it with imaging with a standard volumetric interpolated breath-hold examination (VIBE) sequence, with extra focus on the visibility of bronchi and the signal intensity of lung parenchyma. The study was approved by the local ethics committee, and all subjects gave written informed consent. Twelve healthy volunteers were imaged with PETRA and VIBE sequences. Image quality was evaluated by using visual scoring, numbering of visible bronchi, and quantitative measurement of the apparent contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR). For preliminary clinical assessment, three young patients with cystic fibrosis underwent both MR imaging and computed tomography (CT). Comparisons were made by using the Wilcoxon signed-rank test for means and the McNemar test for ratios. Agreement between CT and MR imaging disease scores was assessed by using the κ test. PETRA imaging was performed with a voxel size of 0.86 mm(3). Overall image quality was good, with little motion artifact. Bronchi were visible consistently up to the fourth generation and in some cases up to the sixth generation. Mean CNR and SNR with PETRA were 32.4% ± 7.6 (standard deviation) and 322.2% ± 37.9, respectively, higher than those with VIBE (P < .001). Good agreement was found between CT and PETRA cystic fibrosis scores (κ = 1.0). PETRA enables silent, free-breathing, isotropic, and submillimeter imaging of the bronchi and lung parenchyma with high CNR and SNR and may be an alternative to CT for patients with cystic fibrosis.Keywords
This publication has 25 references indexed in Scilit:
- Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2014
- HRCT and MRI of the lung in children with cystic fibrosis: Comparison of different scoring systemsJournal of Cystic Fibrosis, 2014
- Quiet T1‐weighted imaging using PETRA: Initial clinical evaluation in intracranial tumor patientsJournal of Magnetic Resonance Imaging, 2014
- Pulmonary 3 T MRI with ultrashort TEs: Influence of ultrashort echo time interval on pulmonary functional and clinical stage assessments of smokersJournal of Magnetic Resonance Imaging, 2013
- Cancer Risks from CT Scans: Now We Have Data, What Next?Radiology, 2012
- Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort studyThe Lancet, 2012
- Ultrashort echo time imaging using pointwise encoding time reduction with radial acquisition (PETRA)Magnetic Resonance in Medicine, 2011
- Computed tomography and magnetic resonance imaging in cystic fibrosis lung diseaseJournal of Magnetic Resonance Imaging, 2010
- The role of advanced imaging techniques in cystic fibrosis follow-up: is there a place for MRI?Pediatric Radiology, 2010
- Visualization of morphological parenchymal changes in emphysema: Comparison of different MRI sequences to 3D-HRCTEuropean Journal of Radiology, 2010